US FDA Gets Less FY2022 Funding From Senate Than House, Different Inspection Priorities
Executive Summary
CDER would receive $17m less in Senate appropriations bill compared to House veion, while CFSAN's total would be nearly $10m less. Overall, Senate bill includes around $50.4m less in funding for FDA than House bill.